Labaz review

Labaz, a prescription medication that alters the hearts rhythm, is defined as an antiarrhythmic medication. It is commonly administered to patients suffering from heart rhythm disorders which can be life threatening when not addressed. Brand names commonly attributed to Labaz include Pacerone, Cordarone, and Cordarone I.V.

Labaz is used to treat ventricular fibrillation or ventricular tachycardia, rhythm disorders of the ventricle found in the lower portion of the heart in charge of moving blood out of the organ. This medication was discovered in 1961 but was only cleared for use in the United States by the FDA in 1985.

Labaz is only used in life-threatening situations due to fatal side effects and severe allergic reactions. Patients allergic to iodine or Labaz should not take this medication. People suffering from heart conditions should consult a doctor before taking this medication. It is mainly used for patients suffering from serious irregular heartbeats of the heart; which includes atrial flutter, atrial fibrillation, ventricular tachycardia, and ventricular fibrillation.

Patients must undergo an extensive physical and medical examination by a doctor prior to taking Labaz. Dosage depends on certain factors and requires that you tell your doctor about the current condition of your body to avoid fatal side effects.

Labaz is administered in the hospital where your condition is carefully monitored to detect and immediately address side effects that could be fatal. Avoid self-medication. This medication should be taken with a full glass of water to properly dilute.

A person taking Labaz should seek immediate medical attention in the event any of the following allergic reactions occur: breathing problems, swelling of the face, lips, throat, or tongue and hives.

Common side effects attributed to Labaz include fast and slow pounding heartbeats, irregular heartbeat pattern, dizziness and fainting, chest pains, flu-like symptoms, blurring of vision, short breathing, weight-loss, sudden body temperature change, increased perspiration, numbness, burning sensation, wamble, vomiting, stomach pain, fever, clay-colored stools, and jaundice. The above-mentioned symptoms might occur during the treatment or a few months after taking the medication. It is very important to consult a doctor if any of these conditions appear to avoid fatal or life-threatening conditions.

Labaz reacts to other medications containing cytochrome P450 isozyme. These include cyclosporine, flecainide, quinidine, simvastatin, warafin, and other medications under the same family. The dose of these medications should be halved to avoid complications. If you are taking any of these medications, make certain your doctor is aware.

Patients suffering from lung disorder (asthma), vision problems, thyroid disorder, liver illness, blood pressure problems, electrolyte imbalance, or heart attachments may require a dose adjustment. Consult your doctor and make certain they are aware of your medical history.

This medication is in Category D Pregnancy. Women who are pregnant or may become pregnant are advised not to take Labaz since it might harm the fetus. Inform your doctor if you become pregnant during treatment to avoid problems. Lactating mothers are advised to avoid breastfeeding since Labaz can be easily passed into breast milk and cause harm to the nursing baby.

Labaz has the following structural formula:

Chemical structure of labaz

• Molecular formula of labaz is C25H29I2NO3
• Chemical IUPAC Name is (2-butylbenzofuran-3-yl)-[4-(2-diethylaminoethoxy)-3,5-diiodo-phenyl]-methanone
• Molecular weight is 645.312 g/mol
Labaz available : 200mg tablets

Generic name: Amiodarone

Brand name(s): Amiodarona, Amiodarons, Amjodaronum, Cordarone, Pacerone

  Your Labaz review